Associations of the TNF-alpha -308 G/A, IL6 -174 G/C and AdipoQ 45 T/G polymorphisms with inflammatory and metabolic responses to lifestyle intervention in Brazilians at high cardiometabolic risk

Diabetology and Metabolic Syndrome

Volumn 4, Issue 1, 2012, Pages

  Curti, Maira L R ^a   Pires, Milena M ^a   Barros, Camila R ^a   Siqueira Catania, Antonela ^a   Rogero, Marcelo MacEdo ^a   Ferreira, Sandra R G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiometabolic risk; Intervention; Lifestyle; Polymorphisms

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; GENOMIC DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ANTHROPOMETRY; ARTICLE; BODY WEIGHT; BRAZIL; CALORIC INTAKE; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; WAIST CIRCUMFERENCE;

EID: 84869881438     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-4-49     Document Type: Article

References (53)

1. Genetics of obesity and type 2 diabetes: tracking pathogenic traits during the predisease period. P Bougnères, Diabetes 2002 51 S3 295 S303 12475766
2. Reduction of serum lipids by soy protein and soluble fiber is not associated with the ABCG5/G8, apolipoprotein E, and apolipoprotein A1 polymorphisms in a group of hyperlipidemic Mexican subjects. N Torres, M Guevara-Cruz, J Granados, et al. Nutr Res 2009 29 10 728 735 10.1016/j.nutres.2009.09.013 19917453
3. Obesity, inflammation and dyslipidemia: implications for nutrigenetics. MLR Curti, P Jacob, MC Borges, et al. J Obes 2011 article ID 497401
4. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. AG Wilson, JA Symons, TL McDowell, et al. Proc Natl Acad Sci USA 1997 94 3195 3199 10.1073/pnas.94.7.3195 9096369 (Pubitemid 27157287)
5. Frequencies of the tumor necrosis factor gene polymorphisms in the Korean population. JY Um, HM Kim, Hereditas 2003 139 3 184 188 15061799
6. The TNF-alpha G-308A polymorphism is associated with C-reactive protein levels: the HERITAGE Family Study. HM Lakka, TA Lakka, T Rankinen, et al. Vascul Pharmacol 2006 44 5 377 383 10.1016/j.vph.2006.02.002 16581306
7. Tumor necrosis factor-alpha-induced insulin resistance in adipocytes. C Qi, PH Pekala, Proc Soc Exp Biol Med 2000 223 128 135 10.1046/j.1525-1373.2000. 22318.x 10654615 (Pubitemid 30339434)
8. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. GS Hotamisligil, NS Shargil, BM Spielgelman, Science 1992 259 87 91 (Pubitemid 23036092)
9. Inflamation and insulin resistance. SE Shoelson, J Lee, AB Goldfine, J Clin Invest 2006 116 1793 1801 10.1172/JCI29069 16823477
10. Obesity, inflammation, and the potential application of pharmaconutrition. MC Cave, RT Hurt, TH Frazier, et al. Nutr Clin Pract 2008 23 16 34 10.1177/011542650802300116 18203961 (Pubitemid 351438965)
11. Relevance of the tumor necrosis factor alpha (TNF alpha) 308 promoter polymorphism in TNF alpha gene regulation. BM Brinkman, D Zuijdeest, EL Kaijzel, et al. J Inflamm 1995 46 1 32 41 8832970
12. Effects of stimulus and cell type on the expression of the 308 tumour necrosis factor promoter polymorphism. KM Kroeger, JH Steer, DA Joyce, et al. Cytokine 2000 12 2 110 119 10.1006/cyto.1999.0529 10671295 (Pubitemid 30449863)
13. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. SK Fried, DA Bunkin, AS Greenberg, J Clin Endocrinol Metab 1998 83 3 847 850 10.1210/jc.83.3.847 9506738 (Pubitemid 28496456)
14. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. A Steensberg, CP Fischer, C Keller, et al. Am J Physiol-endoc M 2003 285 2 433 E437
15. Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery. C Poitou, JM Lacorte, M Coupaye, et al. Obes Surg 2005 15 11 23 10.1381/0960892052993431 15760495 (Pubitemid 40203820)
16. Study of TNFalpha -308 G/A and IL6 174 G/C polymorphisms in type 2 diabetes and obesity risk in the Tunisian population. R Bouhaha, T Baroudi, H Ennafaa, et al. Clin Biochem 2010 6 549 552
17. Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey. A Riikola, K Sipilä M Kähönen, et al. Atherosclerosis 2009 207 2 466 470 10.1016/j.atherosclerosis.2009.06.004 19592000
18. Interleukin-6 gene -174 g > c and -572 g > c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. DJ Brull, HE Montgomery, J Sanders, et al. Arterioscler Thromb Vasc Biol 2001 21 9 1458 1463 10.1161/hq0901.094280 11557672 (Pubitemid 34219808)
19. Peroxisome proliferator-activated receptor (PPAR) modulators: diabetes and beyond. AB Jones, Med Res Rev 2001 21 540 552 10.1002/med.1025 11607934 (Pubitemid 32959242)
20. Association of the IL6-174(G/C) polymorphism with C-reactive protein concentration after weight loss in obese men. C Eklund, A Nenonen, K Kukkonen-Harjula, et al. Eur Cytokine Netw 2006 17 131 135 16840032
21. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. JM Fernandez-Real, M Broch, J Vendrell, et al. J Clin Endocrinol Metab 2000 85 1334 1339 10.1210/jc.85.3.1334 10720087 (Pubitemid 32269397)
22. Obesity, adiponectin and vascular inflammatory disease. N Ouchi, S Kihara, T Funahashi, et al. Curr Opin Lipidol 2003 14 6 561 566 10.1097/00041433-200312000-00003 14624132 (Pubitemid 41623184)
23. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. BI Shand, RS Scott, PA Elder, et al. Diabetes Obes Metab 2003 5 5 349 353 10.1046/j.1463-1326.2003.00279.x 12940874 (Pubitemid 37138867)
24. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. C Weyer, T Funahashi, S Tanaka, et al. J Clin Endocrinol Metab 2001 86 5 1930 1935 10.1210/jc.86.5.1930 11344187 (Pubitemid 32472900)
25. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. M Matsuda, I Shimomura, M Sata, et al. J Biol Chem 2002 277 40 37487 37491 10.1074/jbc.M206083200 12138120
26. Japanese Brazilian Diabetes Study Group. Association of genetic variants in the adiponectin encoding gene (ADIPOQ) with type 2 diabetes in Japanese Brazilians. MF Vendramini, AC Pereira, SR Ferreira, et al. J Diabetes Complic 2010 24 2 115 120 10.1016/j.jdiacomp.2009.01.007
27. Associations between 45 T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. LL Li, XL Kang, XJ Ran, et al. Clin Exp Pharmacol Physiol 2007 34 12 1287 1290 10.1111/j.1440-1681.2007.04713.x 17973869 (Pubitemid 350013237)
28. Influence of adiponectin gene polymorphisms on adiponectin level and insulin resistance index in response to dietary intervention in overweight-obese patients with impaired fasting glucose or newly diagnosed type 2 diabetes. HK Chung, JS Chae, YJ Hyun, et al. Diabetes Care 2009 32 4 552 558 10.2337/dc08-1605 19131459
29. The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. J Zacharova, JL Chiasson, M Laakso, Diabetes 2005 54 3 893 899 10.2337/diabetes.54.3.893 15734870 (Pubitemid 40322096)
30. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. G Musso, R Gambino, F De Michieli, et al. Hepatology 2008 47 4 1167 1177 10.1002/hep.22142 18311774 (Pubitemid 351547903)
31. Association of the C45TG and C276GT polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. L Melistas, CS Mantzoros, M Kontogianni, et al. Eur J Endocrinol 2009 161 845 852 10.1530/EJE-09-0492 19755407
32. Adiponectin and adiponectin receptor gene variants in relation to resting metabolic rate, respiratory quotient, and adiposity-related phenotypes in the Quebec Family Study. RJ Loos, S Ruchat, T Rankinen, et al. Am J Clin Nutr 2007 85 26 34 17209173 (Pubitemid 46067611)
33. Report of the expert committee on the diagnosis and classification of diabetes mellitus. ADA-American Diabetes Association, Diabetes Care 1997 20 1183 1197 9203460
34. International Diabetes Federation: a consensus on Type 2 diabetes prevention. KGMM Alberti, PZ Zimmet, J Shaw, Diabet Med 2007 24 451 463 17470191 (Pubitemid 46669328)
35. International Physical Activity Questionnaire: 12-country reliability and validity. CL Craig, AL Marshall, M Sjöström, et al. Med Sci Sports Exerc 2003 35 8 1381 1395 10.1249/01.MSS.0000078924.61453.FB 12900694 (Pubitemid 36936159)
36. A simple salting out procedure for extracting DNA from human nucleated cells. SA Miller, DD Dykes, HF Polesky, Nucleic Acids Res 1988 16 3 1215 10.1093/nar/16.3.1215 3344216
37. Amplification refractory mutation system for prenatal diagnosis and carrier assessment in cystic fibrosis. CR Newton, LE Heptinstall, C Summers, M Super, Lancet 1989 2 8678-8679 1481 1483 2574768 (Pubitemid 20018142)
38. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. KJ Livak, SJ Flood, J Marmaro, et al. PCR Methods Appl 1995 4 6 357 362 10.1101/gr.4.6.357 7580930
39. HapMap (haplotype map of the human genome) http://www.ncbi.nlm.nih.gov/ SNP/
40. Polymorphisms in the genes encoding TGF-b1, TNF-a, and IL-6 show association with type 1 diabetes mellitus in the Slovak population. J Javor, S Ferencik, M Bucova, et al. Arch Immunol Ther Exp 2010 58 385 393 10.1007/s00005-010-0092-z
41. Distribution and genotype frequency of adiponectin (+45 T/G) and adiponectin receptor2 (+795 G/A) single nucleotide polymorphisms in Iranian population. F Namvaran, N Azarpira, B Geramizadeh, et al. Gene 2011 486 97 103 10.1016/j.gene.2011.07.009 21810455
42. Inflammation and type 2 diabetes. MC Calle, ML Fernandez, Diabetes Metab 2012 38 3 183 191 10.1016/j.diabet.2011.11.006 22252015
43. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. U Meier, AM Gressner, Clin Chem 2004 50 9 1511 1525 10.1373/clinchem.2004.032482 15265818 (Pubitemid 39121218)
44. Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome. SC Sookoian, C González, CJ Pirola, Obes Res 2005 13 12 2122 2131 10.1038/oby.2005.263 16421346
45. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. LJ Abraham, KM Kroeger, J Leukoc Biol 1999 66 4 562 566 10534109 (Pubitemid 29489880)
46. Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis. A Mekinian, R Tamouza, S Pavy, et al. Eur Cytokine Netw 2011 22 2 88 102 21768061
47. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. JMF Fernandez-Real, M Vayreda, C Richart, et al. J Clin Endocrinol Metab 2001 86 1154 1159 10.1210/jc.86.3.1154 11238501 (Pubitemid 32322997)
48. The anti-inflammatory effect of exercise. AM Petersen, BK Pedersen, J Appl Physiol 2005 98 1154 1162 10.1152/japplphysiol.00164.2004 15772055 (Pubitemid 40396484)
49. Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise. D Lyngso, L Simonsen, J Bulow, J Physiol 2002 543 373 378 10.1113/jphysiol.2002.019380 12181307 (Pubitemid 34947322)
50. Special feature for the Olympics: effects of exercise on the immune system: exercise and cytokines. BK Pedersen, Immunol Cell Biol 2000 78 5 532 535 10.1111/j.1440-1711.2000.t01-11-.x 11050536
51. The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women. Y Jang, JS Chae, SJ Koh, et al. Clin Chim Acta 2008 391 85 90 10.1016/j.cca.2008.02.011 18328815
52. Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals. G Mohammadzadeh, N Zarghami, Scand J Clin Lab Invest 2009 69 7 764 771 10.3109/00365510903137237 19929719
53. Polymorphisms of interleukin-1 gene complex, IL6 and tumour necrosis factor genes in chronic idiopathic neutropenia of adults. M Addas-Carvalho, EV de Paula, CS Lima, et al. Ann Hematol 2005 84 11 709 714 10.1007/s00277-005- 1066-9 15986200 (Pubitemid 41460244)